Annual Review of Rheumatology Advances - 2014
This retrospective highlights several of the most impactful publications, trends, research and news that occurred in 2014.
Blogs
Rheumatology Pearls from Twitter - Really?
To many of my colleagues (admitted Luddites) the mere mention of Twitter results in the “omi-god 360” eye roll with an accompanying snide comment.
Letter to the Expert: Is there life after ONJ?
Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?
The Nine Lives of Hydroxychloroquine
The hydroxychloroquine story begins in 1638 when the wife of the Viceroy of Peru, Countess Cinchona, acquired malaria while living in the New World.
Hot Stuff Part IV: Cardiovascular Outcomes and Vasculitis
The last in a four-part series from the CCF's Biologic Therapies Summit, we examine how to reduce CV risks in practice plus the current status of vasulitis management and the role biologics may play.
Top 5 Things Rheumatologists Should Know about Vaccines
Rheumatologists should have a working knowledge on what vaccinations their patients need. The top 5 things rheumatologists should know about vaccines are...
Hot Stuff from the Cleveland Clinic Biologic Therapies Summit – Part I
Highlights and take-home messages from the Cleveland Clinic Center for Continuing Education's Biologic Therapies Summit held this week (April 30 – May 2, 2015).
